Barclays PLC Agios Pharmaceuticals, Inc. Call Options Transaction History

Barclays PLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$27.55 - $48.83 $60,610 - $107,426	2,200 Added 7.33%	32,200 $1.39 Million
Q1 2024 May 15, 2024	SELL	$21.32 - $34.81 $639,600 - $1.04 Million	-30,000 Reduced 50.0%	30,000 $877,000
Q4 2023 Feb 15, 2024	BUY	$19.97 - $24.53 $1.2 Million - $1.47 Million	60,000 New	60,000 $1.34 Million
Q1 2019 May 15, 2019	SELL	$45.92 - $67.67 $6.77 Million - $9.98 Million	-147,500 Reduced 99.8%	300 $20,000
Q4 2018 Feb 14, 2019	BUY	$42.73 - $76.53 $5.16 Million - $9.24 Million	120,800 Added 447.41%	147,800 $6.82 Million
Q1 2018 May 15, 2018	BUY	$59.83 - $86.53 $1.62 Million - $2.34 Million	27,000 New	27,000 $2.21 Million

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.24B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.